Increased expression of hLRH-1 in human gastric cancer and its implication in tumorigenesis

Molecular and Cellular Biochemistry

Volumn 308, Issue 1-2, 2008, Pages 93-100

  Wang, Shui Liang ^a   Zheng, De Zhu ^a   Lan, Feng Hua ^a   Deng, Xiao Jun ^a   Zeng, Jian ^a   Li, Cheng Jin ^a   Wang, Rong ^a   Zhu, Zhong Yong ^a  

^a Dongfang Hospital   (China)

Author keywords

Gastric cancer; HLRH 1; HLRH 1v1; WNT catenin pathway

Indexed keywords

BETA CATENIN; CYCLIN D1; CYCLIN E; CYCLIN E1; LIVER RECEPTOR HOMOLOG 1; LIVER RECEPTOR HOMOLOG 1V1; MESSENGER RNA; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH CARCINOGENESIS; UPREGULATION;

BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYCLIN E; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTEIN ISOFORMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; TRANSFECTION; UP-REGULATION;

EID: 38649119427     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-007-9616-1     Document Type: Article

References (26)

1. Wu M, Xue K (2004) Genetics of tumor. Scientific Press, Beijing, pp 409-435
2. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 1000:57-70
3. Stock M, Otto F (2005) Gene deregulation in gastric cancer. Gene 360:1-19
4. Fayard E, Auwerx J, Schoonjans K (2004) LRH-1: An orphan nuclear receptor involved in development, metabolism and steroidogenesis. Trends Cell Biol 14:250-260
5. Luo Y, Liang CP, Tall AR (2001) The orphan nuclear receptor LRH-1 potentiates the sterol-mediated induction of the human CETP gene by liver X receptor. J Biol Chem 276:24767-24773
6. Schoonjans K, Annicotte J, Huby T et al. (2002) Liver receptor homolog 1 controls the expression of the scavenger receptor class B type I. EMBO R 3:1181-1187
7. Goodwin B, Jones SA, Price RR et al. (2000) A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6:517-526
8. Lu TT, Makishima M, Repa JJ et al. (2000) Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6:507-515
9. Botrugno OA, Fayard E, Annicotte J et al. (2004) Synergy between LRH-1 and β-catenin induces G1 cyclin-mediated cell proliferation. Mol Cell 15:499-509
10. Zhou J, Suzuki T, Kovacic A et al. (2005) Interactions between prostaglandin E2, liver receptor homologue-1, and aromatase in breast cancer. Cancer Res 65:657-663
11. Annicotte JS, Chavey C, Servant N et al. (2005) The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene. Oncogene 24:8167-8175
12. Schoonjans K, Dubuquoy L, Mebis J, et al (2005) Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation. Proc Natl Acad Sci USA 102:2058-2062
13. Nitta M, Ku S, Brown C et al (1999) CPF: An orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7α-hydroxylase gene. Proc Natl Acad Sci USA 96:6660-6665
14. Candidus S, Bischoff P, Becker KF et al (1996) No evidence for mutations in the alpha- and beta-catenin genes in human gastric and breast carcinomas. Cancer Res 56:49-52
15. Woo DK, Kim HS, Lee HS et al (2001) Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines. Int J Cancer 95:108-113
16. Lee JH, Abraham SC, Kim HS et al (2002) Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. Am J Pathol 161:611-618
17. Abraham SC, Park SJ, Lee JH et al. (2003) Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes. Mod Path 16:786-795
18. Moon RT, Kohn AD, De Ferrari GV et al (2004) WNT and β-catenin signalling: Diseases and therapies. Nat Rev 5:689-699
19. Morin PJ, Sparks AB, Korinek V et al (1997) Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275:1787-1790
20. Tetsu O, McCormick F (1999) β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426
21. He TC, Sparks AB, Rago C et al (1998) Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512
22. Koh TJ, Bulitta CJ, Fleming JV et al (2000) Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis. J Clin Invest 106:533-539
23. Yamada T, Takaoka AS, Naishiro Y et al (2000) Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis. Cancer Res 60:4761-4766
24. Crawford HC, Fingleton BM, Rudolph-Owen LA et al (1999) The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 18:2883-2891
25. Kolligs FT, Bommer G, Goke B et al (2002) Wnt/beta-catenin/tcf signaling: A critical pathway in gastrointestinal tumorigenesis. Digestion 66:131-144
26. Ebert MP, Fei M, Kahmann S et al (2002) Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer. Carcinogenesis 23:87-91